Esi Domi

Dr. Esi Domi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2018 in Science
Verified
Journal Article
Closed access
PDF file
EAEric Augier
Eric Augier
EBEstelle Barbier
Estelle Barbier
RDRussell S. Dulman
Russell S. Dulman
VLValentina Licheri
Valentina Licheri
GAGaëlle Augier
Gaëlle Augier
MHMarkus Heilig
Markus Heilig
Finding the vulnerable minority: “Only” about 10 to 15% of people exposed to alcohol develop alcohol-related problems. The behavioral repertoire of people confronted with opportunities to consume alcohol involves numerous choices between this drug reward and healthy alternatives. Augier et al. established a choice procedure that begins to address alcohol addiction in rats (see the Perspective by Spanagel). They found that a minority of outbred rats continued to self-administer alcohol even when a high-value alternative (such as sugar) was available. That minority displayed a remarkable constellation of behavioral traits resembling the human clinical condition, including a high motivation to obtain alcohol and continued use despite adverse consequences. The cause was impaired GABA (γ-aminobutyric acid) clearance in the central amygdala. Postmortem tissue analysis supported the possibility of a similar pathology in human alcoholism. Science , this issue p. 1321 ; see also p. 1298

1 November 2017 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
AHAnita C Hansson
Anita C Hansson
AKAnne Koopmann
Anne Koopmann
SUStefanie Uhrig
Stefanie Uhrig
SBSina Bühler
Sina Bühler
EDEsi Domi
Esi Domi
RSRainer Spanagel
Rainer Spanagel

20 August 2021 in Science Advances
Verified
Journal Article
Open access
EDEsi Domi
Esi Domi
LXLi Xu
Li Xu
STSanne Toivainen
Sanne Toivainen
ANAnton Nordeman
Anton Nordeman
FGFrancesco Gobbo
Francesco Gobbo
MHMarkus Heilig
Markus Heilig
Inhibitory PKCδ-expressing neurons in the central nucleus of the amygdala promote compulsive alcohol use in rats.

5 February 2018 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
EDEsi Domi
Esi Domi
EBE Barbier
E Barbier
EAE Augier
E Augier
GAG Augier
G Augier
DGD Gehlert
D Gehlert
MHM Heilig
M Heilig

3 November 2016 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EDEsi Domi
Esi Domi
SUStefanie Uhrig
Stefanie Uhrig
LSLaura Soverchia
Laura Soverchia
RSRainer Spanagel
Rainer Spanagel
AHAnita C. Hansson
Anita C. Hansson
MUMassimo Ubaldi
Massimo Ubaldi
PPARγ is one of the three isoforms of the Peroxisome Proliferator-Activated Receptors (PPARs). PPARγ is activated by thiazolidinediones such as pioglitazone and is targeted to treat insulin resistance. PPARγ is densely expressed in brain areas involved in regulation of motivational and emotional processes. Here, we investigated the role of PPARγ in the brain and explored its role in anxiety and stress responses in mice. The results show that stimulation of PPARγ by pioglitazone did not affect basal anxiety, but fully prevented the anxiogenic effect of acute stress. Using mice with genetic ablation of neuronal PPARγ (PPARγNestinCre), we demonstrated that a lack of receptors, specifically in neurons, exacerbated basal anxiety and enhanced stress sensitivity. The administration of GW9662, a selective PPARγ antagonist, elicited a marked anxiogenic response in PPARγ wild-type (WT), but not in PPARγNestinCreknock-out (KO) mice. Using c-Fos immunohistochemistry, we observed that acute stress exposure resulted in a different pattern of neuronal activation in the amygdala (AMY) and the hippocampus (HIPP) of PPARγNestinCreKO mice compared with WT mice. No differences were found between WT and KO mice in hypothalamic regions responsible for hormonal response to stress or in blood corticosterone levels. Microinjection of pioglitazone into the AMY, but not into the HIPP, abolished the anxiogenic response elicited by acute stress. Results also showed that, in both regions, PPARγ colocalizes with GABAergic cells. These findings demonstrate that neuronal PPARγ is involved the regulation of the stress response and that the AMY is a key substrate for the anxiolytic effect of PPARγ.SIGNIFICANCE STATEMENTPeroxisome Proliferator-Activated Receptor Gamma (PPARγ) is a classical target for antidiabetic therapies with thiazolidinedione compounds. PPARγ agonists such as rosiglitazone and pioglitazone are in clinical use for the treatment of insulin resistance. PPARγ has recently attracted attention for its involvement in the regulation of CNS immune response and functions. Here, we demonstrate that neuronal PPARγ activation prevented the negative emotional effects of stress and exerted anxiolytic actions without influencing hypothalamic–pituitary–adrenal axis function. Conversely, pharmacological blockade or genetic deletion of PPARγ enhanced anxiogenic responses and increased vulnerability to stress. These effects appear to be controlled by PPARγ neuronal-mediated mechanisms in the amygdala.

11 March 2021 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
EDEsi Domi
Esi Domi
ADAna Domi
Ana Domi
LALouise Adermark
Louise Adermark
MHMarkus Heilig
Markus Heilig
EAEric Augier
Eric Augier
Alcohol addiction is a chronic relapsing brain disease characterized by an impaired ability to stop or control alcohol use despite adverse consequences. A main challenge of addiction treatment is to prevent relapse, which occurs in more than >50% of newly abstinent patients with alcohol disorder within 3 months. In people suffering from alcohol addiction, stressful events, drug‐associated cues and contexts, or re‐exposure to a small amount of alcohol trigger a chain of behaviors that frequently culminates in relapse. In this review, we first present the preclinical models that were developed for the study of alcohol seeking behavior, namely the reinstatement model of alcohol relapse and compulsive alcohol seeking under a chained schedule of reinforcement. We then provide an overview of the neurobiological findings obtained using these animal models, focusing on the role of opioids systems, corticotropin‐release hormone and neurokinins, followed by dopaminergic, glutamatergic, and GABAergic neurotransmissions in alcohol seeking behavior. image